
Earkart Limited IPO
Earkart Limited IPO is a SME fixed price IPO. Issue size is ₹49.26 Cr. Price band is ₹135 per share. Minimum investment is ₹2.70 L. Lot size is 1000 shares. Open from 25 Sept 2025 to 29 Sept 2025. Allotment on 29 Sept 2025. Listing on 2 Oct 2025 at BSE. Managed by Sarthi Capital Advisors Pvt.Ltd. Registrar: Skyline Financial Services Private Ltd. Key details for GMP, subscription, price, allotment, and listing in one place.
Official documents:DRHP.
Earkart Limited IPO overview
Earkart Limited IPO Key figures
Price band, lot, minimum application, and issue window at a glance.
Earkart Limited IPO important dates
Earkart Limited IPO lot size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | ₹2,70,000 |
| S-HNI (Min) | 3 | 3,000 | ₹4,05,000 |
| S-HNI (UPI) | 3 | 3,000 | ₹4,05,000 |
| S-HNI (Max) | 7 | 7,000 | ₹9,45,000 |
| B-HNI (Min) | 8 | 8,000 | ₹10,80,000 |
About Earkart Limited IPO
From the company / RHP narrative.
It also offers and distributes other products like adjustable foldable walkers and Multi-Sensory Integrated Educational Development (MSIED) and Teaching Learning Material (TLM) for physically challenged.
The company sells products through a network of partners and clinics, both domestically and globally. It is also a trusted Government e-Market (GeM) supplier of hearing aids to ALIMCO under Ministry of Social Justice and Empowerment.
In April 2024, the company has launched Shop in Shop (SIS) model, wherein it offers franchise to opticians and ENT/optical clinics. As on date, the company operates 49 SIS clinics across 22 cities in 6 states and 2 Union Territories, i.e., Haryana, Uttar Pradesh, Rajasthan, Punjab, Jharkhand, Delhi, Uttarakhand, and Chandigarh.
Its manufacturing facility is located in Noida, across 4,500 square feet
Competitive Strengths:
Various types of hearing aids products
Multi-channel product distribution network: Online, offline, and B2G sales
Continued focus on innovation and technology
Objective of the issue
How the issuer plans to use IPO proceeds.
Funding capital expenditure requirements for setting of Shop in Shop (SIS) Business Model in ENT/Ophthalmic Clinics across India and Setting up of Infrastructure for operational activities
General Corporate Purposes
Ratings & reviews
Community ratings and reviews — not financial advice.
No ratings yet — be the first to share your experience.
Follow the latest IPO & unlisted research on iOS and Android.
Documents & links
Prospectus, draft filings, and company site open in a new tab.
Registrar
Details about the registrar of the issue.
Issue details
Key details about the issue, including the face value, lot size, and minimum investment.
Related articles
Research posts and updates that reference this company or theme.
Follow the latest IPO & unlisted research on iOS and Android.